Methods for making an aqueous radiation protecting formulation
View Patent ↗Medical devices are typically sterilized in processes used to manufacture such products and their sterilization by exposure to radiation is a common practice. Radiation has a number of advantages over other sterilization processes including a high penetrating ability, relatively low chemical reactivity, and instantaneous effects without the need to control temperature, pressure, vacuum, or humidity. Unfortunately, radiation sterilization can compromise the function of certain components of medical devices. For example, radiation sterilization can lead to loss of protein activity and/or lead to bleaching of various dye compounds. Embodiments of the invention provide methods and materials that can be used to protect medical devices from unwanted effects of radiation sterilization.
1. A method of inhibiting damage to a saccharide sensor that can result from a radiation sterilization process, the method comprising combining the saccharide sensor with an aqueous radioprotectant formulation during the sterilization process, wherein:
the saccharide sensor comprises a saccharide binding polypeptide;
the aqueous radioprotectant formulation comprises an antioxidant compound; and
performing the sterilization process under conditions wherein the antioxidant reacts with a free radical compound produced during the radiation sterilization process, wherein the free radical compound can react with and damage the saccharide binding polypeptide.
2. The method of claim 1 , wherein the saccharide binding polypeptide comprises mannan binding lectin, concanavalin A or glucose oxidase.
3. The method of claim 1 , wherein the saccharide comprises glucose, mannose, fructose, melizitose, N-acetyl-D-glucosamine, sucrose or trehalose.
4. The method of claim 1 , wherein the aqueous radioprotectant formulation comprises an antioxidant compound selected from the group consisting of ascorbate, urate, nitrite, vitamin E, α-tocopherol or nicotinate methylester.
5. The method of claim 1 , wherein:
the saccharide sensor comprises a fluorophore; and
the aqueous radioprotectant formulation comprises a fluorophore quenching composition selected for its ability to quench the fluorophore.
6. The method of claim 1 , wherein the aqueous radioprotectant formulation comprises a buffering agent.
7. The method of claim 6 , wherein the buffering agent is selected from the group consisting of citrate, tris(hydroxymethyl)aminomethane (TRIS) and tartrate.
8. The method of claim 1 , wherein the aqueous radioprotectant formulation comprises a surfactant.
9. The method of claim 1 , wherein the radiation sterilization process comprises a single dose of radiation.
10. The method of claim 1 , wherein the radiation sterilization process comprises electron beam irradiation.